EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Liposomal Formulations Containing Amino Acid Menthol Ester Naproxenate: Physicochemical Characterization and Transdermal Delivery Potential

Aleksandra Bilska, Karolina Bilska, Anna Nowak, Grzegorz Story, Łukasz Struk, Paula Ossowicz-Rupniewska

Applied Sciences · 05.08.2026 · 16 (15) · 7813

DOI: 10.3390/app16157813 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Applied Sciences, online erschienen am 05.08.2026. Verfasst von Aleksandra Bilska und 5 weiteren Autor:innen. Die Arbeit nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Non-steroidal anti-inflammatory drugs (NSAIDs), including naproxen, are widely used for the treatment of pain and inflammation; however, their therapeutic application is limited by poor aqueous solubility and low bioavailability. This study aimed to synthesize and characterize a novel amino acid-based naproxen derivative, L-phenylalanine menthol ester naproxenate ([PheOMent][NAP]), develop liposomal formulations containing the obtained compound, and evaluate their physicochemical properties and transdermal delivery potential. The derivative was synthesized via a three-step procedure and characterized using NMR, FT-IR, TG, DSC, and XRD analyses. Compared with naproxen, [PheOMent][NAP] exhibited lower lipophilicity (log P = 1.36 vs. 1.70). Liposomal formulations containing the modified derivative showed high encapsulation efficiency (89.6–90.7%), higher than that observed for naproxen-loaded liposomes (51.7–54.7%). The prepared systems exhibited bimodal particle size distributions, comprising both submicrometre and micrometre vesicle populations depending on the preparation method, as well as negative zeta potential values (−18.17 to −23.72 mV) and pH values ranging from 6.18 to 7.07, demonstrating physicochemical characteristics suitable for topical formulations. In vitro permeation studies using porcine skin demonstrated markedly enhanced transdermal delivery of [PheOMent][NAP]. After 24 h, cumulative permeation exceeded that of naproxen formulations by more than 1.5-fold (416.7 vs. 281.6 μg cm−2). These findings indicate that liposomal formulations containing amino acid-modified naproxen derivatives represent a promising strategy for improving transdermal NSAID delivery.

Zitieren

APA

Bilska, A., Bilska, K., Nowak, A., Story, G., Struk, Ł., & Ossowicz-Rupniewska, P. (2026). Liposomal Formulations Containing Amino Acid Menthol Ester Naproxenate: Physicochemical Characterization and Transdermal Delivery Potential. Applied Sciences, 16(15), 7813. https://doi.org/10.3390/app16157813

Vancouver

Bilska A, Bilska K, Nowak A, Story G, Struk Ł, Ossowicz-Rupniewska P. Liposomal Formulations Containing Amino Acid Menthol Ester Naproxenate: Physicochemical Characterization and Transdermal Delivery Potential. Applied Sciences. 2026;16(15):7813. doi:10.3390/app16157813

BibTeX
@article{Bilska2026,
  author = {Bilska, Aleksandra and Bilska, Karolina and Nowak, Anna and Story, Grzegorz and Struk, Łukasz and Ossowicz-Rupniewska, Paula},
  title = {Liposomal Formulations Containing Amino Acid Menthol Ester Naproxenate: Physicochemical Characterization and Transdermal Delivery Potential},
  journal = {Applied Sciences},
  year = {2026},
  volume = {16},
  number = {15},
  pages = {7813},
  doi = {10.3390/app16157813}
}
Kostenlos starten →